Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Common Equity: 2013-2024

Historic Common Equity for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $3.2 billion.

  • Surgery Partners' Common Equity rose 96.73% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 96.73%. This contributed to the annual value of $3.2 billion for FY2024, which is 533.53% up from last year.
  • According to the latest figures from FY2024, Surgery Partners' Common Equity is $3.2 billion, which was up 533.53% from $3.0 billion recorded in FY2023.
  • Surgery Partners' Common Equity's 5-year high stood at $3.2 billion during FY2024, with a 5-year trough of $882.1 million in FY2020.
  • Over the past 5 years, Surgery Partners' median Common Equity value was $2.9 billion (recorded in 2022), while the average stood at $2.4 billion.
  • Its Common Equity has fluctuated over the past 5 years, first crashed by 1030.1% in 2020, then surged by 12328.53% in 2021.
  • Surgery Partners' Common Equity (Annual) stood at $882.1 million in 2020, then soared by 123.29% to $2.0 billion in 2021, then skyrocketed by 49.31% to $2.9 billion in 2022, then rose by 3.18% to $3.0 billion in 2023, then rose by 5.34% to $3.2 billion in 2024.
  • Its last three reported values are $3.2 billion in FY2024, $3.0 billion for FY2023, and $2.9 billion during FY2022.